Serious staphylococcal infections - Cyclic lipopeptides: Meeting new challenges

Clinical Microbiology and Infection

Volumn 14, Issue SUPPL. 2, 2008, Pages 1-2

  Graninger, Wolfgang ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

DAPTOMYCIN; METICILLIN; PENICILLIN DERIVATIVE; PENICILLINASE RESISTANT PENICILLIN; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BACTEREMIA; BACTERIAL ENDOCARDITIS; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; HEALTH CARE COST; HUMAN; LEG ULCER; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PRIORITY JOURNAL; SKIN INFECTION; SOFT TISSUE INFECTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; VANCOMYCIN RESISTANT STAPHYLOCOCCUS AUREUS;

EID: 38649132896     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2008.01920.x     Document Type: Article

References (9)

1. Bouza E, Finch R. Infections caused by Gram-positive bacteria: Situation and challenges of treatment. Clin Microbiol Infect 2001; 7 (suppl 4): iii.
2. Gonzalez-Romo F, Rubio M, Betriu C et.al. Prevalence and treatment of Gram-positive infections in internal medicine departments of Spanish hospitals: IGP Study. Rev Esp Quimioter 2003; 16: 428-435.
3. EARSS. European Antimicrobial Resistance Surveillance System Annual Report 2005; Bilthoven: EARSS Management Team, 2005.
4. Noskin GA, Rubin RJ, Schentag JJ et.al. The burden of Staphylococcus aureus infections on hospitals in the United States: An analysis of the 2000 and 2001 Nationwide Inpatient Sample Database. Arch Intern Med 2005; 165: 1756-1761.
5. Daxboeck F, Budic T, Assadian O et.al. Economic burden associated with multi-resistant Gram-negative organisms compared with that for methicillin-resistant Staphylococcus aureus in a university teaching hospital. J Hosp Infect 2006; 62: 214-218.
6. Boyle-Vavra S, Daum RS. Community-acquired methicillin-resistant Staphylococcus aureus: The role of Panton-Valentine leukocidin. Lab Invest 2007; 87: 3-9.
7. Arbeit RD, Maki D, Tally FP et.al. The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections. Clin Infect Dis 2004; 38: 1673-1681.
8. Fowler VG Jr, Boucher HW, Corey GR et.al. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med 2006; 355: 653-665.
9. Fowler VG Jr, Olsen MK, Corey GR et.al. Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch Intern Med 2003; 163: 2066-2072.